市場調查報告書
商品編碼
1433430
全球多組學市場 2023-2030Global Multiomics Market 2023-2030 |
預計在預測期內(2024-2031年),全球多組學市場將以 16.5%的複合CAGR成長。多組學技術的進步及其在多種疾病治療中的不斷成長的應用是推動全球市場成長的關鍵因素。多組學新應用領域的發現進一步促進了市場成長。2023年3月,研究人員產生了包括子宮肌層在內的整個人類-母體-胎兒界面的空間分辨多組學單細胞圖譜,這使他們能夠解析妊娠前三個月滋養層分化的完整軌跡。
研究人員對單細胞基因組學日益濃厚的興趣進一步促進了市場的成長。根據國家醫學圖書館2023年 3月發表的研究,單細胞基因體學在心血管疾病研究領域有廣泛的應用。它可用於心臟發育、心肌梗塞、心臟再灌注損傷、動脈粥狀硬化、心房顫動、心臟肥大和心臟衰竭。
Global Multiomics Market Size, Share & Trends Analysis Report by Product & Services (Product and Services), by Type (Single-cell Multiomics and Bulk Multiomics), by Application (Cell Biology, Oncology, Neurology, and Immunology), by End-User (Pharma & Biotech Companies, Academics & Research Organization, and Hospital & Diagnostic Laboratories), Forecast Period (2024-2031)
The global multiomics market is anticipated to grow at a considerable CAGR of 16.5% during the forecast period (2024-2031). Advancements in multiomics technology along with its growing application in the treatment of several disorders is a key factor driving the growth of the global market. The discovery of new application areas of multiomics is further aiding the market growth. In March 2023, the researchers generated a spatially resolved multiomics single-cell atlas of the entire human-maternal-fetal interface including the myometrium, which enables them to resolve the full trajectory of trophoblast differentiation during the first trimester of pregnancy.
The growing interest of researchers in single-cell genomics is further contributing to the market growth. As per the research published by the National Library of Medicine in March 2023, single-cell genomics is found to have numerous applications in the field of cardiovascular disorder research. It can be utilized in heart development, Myocardial Infarction, Cardiac reperfusion injury, atherosclerosis, atrial fibrillation, cardiac hypertrophy, and heart failure.
Looking towards the potential of this market, new startups are entering into this field with funding from venture capitalists. In December 2023, Pepper Bio developer of the COMPASS platform announced an oversubscribed $6.5 million seed round with participation from NFX, Merck Digital Sciences Studio, Mana Ventures, Silverton Partners, Tensility Ventures, VSC Ventures, and others. This funding will accelerate Pepper Bio's transomics platform capabilities, fueling the pipeline.
The global multiomics market is segmented based on product & services, type, application, and end-user. Based on products & services, the market is segmented into products & services. Product is further sub-segmented into instruments, consumables, and software. Based on type, the market is segmented into single-cell multiomics and bulk multiomics. Based on application, the market is segmented into cell biology, oncology, neurology, and immunology. Based on end-user, the market is segmented into
The growing demand for numerous multiomics services has promoted market players to launch several services in the market. New product launches are a key factor driving the growth of this market segment. In September 2023, Multiomics CRO Psomagen launched Spatial Biology services for 10X Genomics Xenium. This platform is reshaping spatial biology, enabling researchers worldwide to analyze the interplay of genes and proteins within their native tissue context. This marks a pivotal moment in the scientific community's access to spatial genomics. Further, in April 2021, Mission Bio launched its Pharma Assay Development (PAD) service, enabling its customers to obtain early access services based on the newest technologies as well as on its existing products. This will support users to implement single-cell multiomics capabilities in their drug discovery, translation, and clinical research endeavors in oncology.
The global multiomics market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Asia-Pacific is anticipated to exhibit considerable growth in the global market. The growing interest of regional pharmaceutical companies in the R&D of genomics is a key factor driving the regional market growth.
The regional market share is driven by the high R&D activities across the region in the fields of genomics, transcriptomics, proteomics, and metabolomics owing to the presence of several key market players. Additionally, increasing investment and government initiatives in this field are also contributing to the high share of the regional market. For instance, in November 2023, The Texas A&M University System received a $1.19 million grant from the National Institutes of Health (NIH) for a multidisciplinary collaboration to study the intricate connections between genomics, nutrition, and health. Understanding these connections will help in the diagnosis and treatment of cancer and other diseases.
The major companies serving the global multiomics market include Bio Rad Laboratories, Inc., Thermo Fischer Scientific Inc., Mission Bio, Inc., Danaher Corp., and Illumina among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, funding, and advancement in their software offerings to stay competitive in the market. For instance, in April 2023, Bio-Techne entered a strategic partnership with Lunaphore for the development of a fully automated spatial multiomics solution. Under the partnership, the companies will engage in the development of the first fully automated spatial multiomics workflow for same-slide hyperplex detection of protein and RNA biomarkers. The new solution is expected to offer ultimate flexibility in panel design. It will support researchers to easily incorporate antibodies with RNAscope in situ hybridization probes to highlight changes in cell phenotypes and functional states across different diseases.